A pilot randomised controlled trial to evaluate the utility and efficacy of neutral argon plasma (PlasmaJet®) as a new technology in achieving complete debulking of advanced Epithelial Ovarian Cancer
Not Applicable
Completed
- Conditions
- Advanced (Stage 3/4) Epithelial Ovarian CancerCancerOvarian Cancer
- Registration Number
- ISRCTN26261491
- Lead Sponsor
- Royal Surrey County Hospital NHS Foundation Trust (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
1. Imaging+/- Clinical +/- laparoscopic e/o pelvic mass and metastatic disease (FIGO III/IV disease) at presentation
2. Confirmation of malignancy on histological/cytological criteria
3. All women aged 18 or over with newly diagnosed FIGO stage III to Stage IV EOC undergoing surgical treatment
4. All women fit to undergo treatment
5. No synchronous malignancy likely to interfere with comparisons
6. Written and informed patient consent
Exclusion Criteria
1. Patient choice
2. Patient unfit for any treatment modality
3. Patients who are medically unfit for surgery and would only be suitable for chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method